Table 3.
Annual costs (in $US millions) associated with CA-MRSA infections and SSTIs only in the US and in the military and jail system sub-populations
| Incidence Estimate | Third-Party Payer Perspective |
Societal Perspective |
|---|---|---|
| All CA-MRSA Infections Annual US Burden | ||
| Study 1 | ||
| 36.4% of Cases are Pediatric | 560 (478 – 644) | 2,685 (1,621 – 3,464) |
| 10.1% of Cases are Pediatric | 562 (469 – 632) | 2,961 (1,494 – 3,989) |
| Study 2 | ||
| 36.4% of Cases are Pediatric | 1,951 (1,665 – 2,244) | 9,350 (5,646 – 12,063) |
| 10.1% of Cases are Pediatric | 1,958 (1,630 – 2,187) | 10,311 (5,205 – 13,892) |
| Study 3 | ||
| 36.4% of Cases are Pediatric | 5,363 (4,577 – 6,169) | 25,701 (15,520 – 33,159) |
| 10.1% of Cases are Pediatric | 5,509 (5,159 – 6,011) | 28,343 (14,308 – 38,186) |
| SSTI Annual US Burden^ | ||
| Study 3 | ||
| 521 per 100,000* | 343 (259 – 451) | 393 (312 –503) |
| Study 4 | ||
| 164.2 per 100,000* | 108 (82 – 142) | 124 (98 – 159) |
| Military | ||
| 15 per 1,000* | 14 | 16 |
| 25 per 1,000* | 23 | 26 |
| 35 per 1,000[24] | 32 | 36 |
| Jail System | ||
| 10 per 1,000* | 6 | 7 |
| 12 per 1,000* | 7 | 8 |
| 15.84 per 1000[25] | 10 | 11 |
Estimated Incidence
83% require I&D